COMPANY OVERVIEW

ReViral is a UK-based biotechnology company developing first in class drugs to treat RSV infections.

---

LOCATION

Stevenage, Hertfordshire, UK

---

THERAPEUTIC AREAS

Infectious Disease

---

WEBSITE

https://www.reviral.co.uk/home

---

CAREER WEBSITE

None

---

SOCIAL MEDIA

---

INVESTORS

---

---

PRESS RELEASES

Jun 9, 2022

Pfizer Completes Acquisition of ReViral

Apr 7, 2022

Pfizer to Acquire ReViral and Its Respiratory Syncytial Virus Therapeutic Candidates

Apr 7, 2022

Andera Partners to sell its Life Sciences’ portfolio company ReViral to Pfizer

Apr 7, 2022

Novo Holdings Portfolio Company ReViral to be Acquired by Pfizer

Apr 7, 2022

LianBio’s Partner ReViral Enters into Acquisition Agreement with Pfizer

For More Press Releases

---